Imidazol-1-yl-acetic Acid CAS 22884-10-2

Product Description:

Product Name: Imidazol-1-yl-acetic acid CAS NO: 22884-10-2

Synonyms:

(1-Imidazolyl)acetic Acid;

1-carboxymethylimidazole;

2-(1H-Imidazol-1-yl)acetic acid;

Chemical & Physical Properties:

Appearance: White crystalline powder

Assay :≥99.00%

Density: 1.33 g/cm3

Boiling Point: 392.1℃ at 760 mmHg

Melting Point: 257-260℃

Flash Point: 190.9℃

Refractive Index: 1.588

Vapor Pressure: 7.49E-07mmHg at 25℃

Safety Information:

HS Code: 2933290090

Risk Statements: R36/37/38

Hazard Code: Xi

Symbol: GHS05, GHS07

Signal Word: Danger

Hazard Statements: H315-H318-H335

Precautionary Statements: P280-P305 + P351 + P338 + P310

Zoledronic acid EP impurity D is an impurity produced in the process of zoledronic acid synthesis, which is mainly used as a reference substance in the process of chemical and pharmaceutical synthesis. Bisphosphonates (BPs) are a new class of drugs used for various bone diseases and calcium metabolic diseases. They can specifically combine with hydroxyapatite in bone, inhibit the activity of osteoclasts, and thus inhibit bone resorption. They are widely used in the treatment of osteoporosis, deformation osteitis, hypercalcemia and tumor-related bone diseases. Zoledronic acid and other bisphosphonic acid drugs have strong anti-bone absorption effect and mechanism. By directly changing the morphology of osteoclasts, they inhibit the formation of actin and interfere with the absorption and reabsorption of osteoclasts to bone. It also inhibits the release of peptides in the bone matrix, breaking the vicious cycle between tumor and bone formation known as the "seed and soil mechanism" and inhibiting tumor cell growth. Zoledronic acid EP impurity D is an impurity produced during the synthesis of zoledronic acid.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.